{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:33:03Z","timestamp":1791765183641,"version":"4.3.4"},"reference-count":170,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30-A008748"],"award-info":[{"award-number":["P30-A008748"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Tumor-related epilepsy (TRE) is a frequent and major consequence of brain tumors. Management of TRE is required throughout the course of disease and a deep understanding of diagnosis and treatment is key to improving quality of life. Gross total resection is favored from both an oncologic and epilepsy perspective. Shared mechanisms of tumor growth and epilepsy exist, and emerging data will provide better targeted therapy options. Initial treatment with antiseizure medications (ASM) in conjunction with surgery and\/or chemoradiotherapy is typical. The first choice of ASM is critical to optimize seizure control and tolerability considering the effects of the tumor itself. These agents carry a potential for drug\u2013drug interactions and therefore knowledge of mechanisms of action and interactions is needed. A review of adverse effects is necessary to guide ASM adjustments and decision-making. This review highlights the essential aspects of diagnosis and treatment of TRE with ASMs, surgery, chemotherapy, and radiotherapy while indicating areas of uncertainty. Future studies should consider the use of a standardized method of seizure tracking and incorporating seizure outcomes as a primary endpoint of tumor treatment trials.<\/jats:p>","DOI":"10.1093\/neuonc\/noad154","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T17:29:47Z","timestamp":1694539787000},"page":"7-24","source":"Crossref","is-referenced-by-count":106,"title":["Brain tumor-related epilepsy management: A Society for Neuro-oncology (SNO) consensus review on current management"],"prefix":"10.1093","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8489-2090","authenticated-orcid":false,"given":"Edward K","family":"Avila","sequence":"first","affiliation":[{"name":"Department of Neurology, Memorial Sloan Kettering Cancer Center , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9071-8398","authenticated-orcid":false,"given":"Steven","family":"Tobochnik","sequence":"additional","affiliation":[{"name":"Department of Neurology, Brigham and Women\u2019s Hospital , Boston, Massachusetts , USA"},{"name":"Department of Neurology, VA Boston Healthcare System , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7587-5085","authenticated-orcid":false,"given":"Sara K","family":"Inati","sequence":"additional","affiliation":[{"name":"Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health , Bethesda, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3648-9616","authenticated-orcid":false,"given":"Johan A F","family":"Koekkoek","sequence":"additional","affiliation":[{"name":"Department of Neurology, Leiden University Medical Center , Leiden , The Netherlands"},{"name":"Department of Neurology, Haaglanden Medical Center , The Hague , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9695-3564","authenticated-orcid":false,"given":"Guy M","family":"McKhann","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4399-0257","authenticated-orcid":false,"given":"James J","family":"Riviello","sequence":"additional","affiliation":[{"name":"Division of Neurology and Developmental Neuroscience, Department of Pediatrics, Baylor College of Medicine, Texas Children\u2019s Hospital , Houston, Texas , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Rud\u00e0","sequence":"additional","affiliation":[{"name":"Division of Neuro-Oncology, Department of Neuroscience \u201cRita Levi Montalcini,\u201d University of Turin , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1561-9220","authenticated-orcid":false,"given":"David","family":"Schiff","sequence":"additional","affiliation":[{"name":"Department of Neurology, Division of Neuro-Oncology, University of Virginia School of Medicine , Charlottesville, Virginia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4536-3791","authenticated-orcid":false,"given":"William O","family":"Tatum","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic , Jacksonville, Florida , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1850-8868","authenticated-orcid":false,"given":"Jessica W","family":"Templer","sequence":"additional","affiliation":[{"name":"Department of Neurology, Northwestern University , Chicago, Illinois , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1748-174X","authenticated-orcid":false,"given":"Michael","family":"Weller","sequence":"additional","affiliation":[{"name":"Department of Neurology, Clinical Neuroscience Centre, University Hospital Zurich and University of Zurich , Zurich , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2452-0540","authenticated-orcid":false,"given":"Patrick Y","family":"Wen","sequence":"additional","affiliation":[{"name":"Center for Neuro-Oncology, Dana-Farber Cancer Center, and Division of Neuro-Oncology, Department of Neurology, Brigham and Women\u2019s Hospital , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,9,12]]},"reference":[{"issue":"10","key":"2024010518031104400_CIT0001","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1212\/WNL.54.10.1886","article-title":"Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"54","author":"Glantz","year":"2000","journal-title":"Neurology."},{"issue":"1","key":"2024010518031104400_CIT0002","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0959-8049(97)00374-2","article-title":"Prevalence and prognostic significance of epilepsy in patients with gliomas","volume":"34","author":"Lote","year":"1998","journal-title":"Eur J Cancer."},{"issue":"1","key":"2024010518031104400_CIT0003","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3171\/2020.12.JNS203351","article-title":"Glioma-related epilepsy in patients with diffuse high-grade glioma after the 2016 WHO update: seizure characteristics, risk factors, and clinical outcomes","volume":"136","author":"Li","year":"2022","journal-title":"J Neurosurg."},{"issue":"1","key":"2024010518031104400_CIT0004","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin."},{"issue":"5","key":"2024010518031104400_CIT0005","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3322\/caac.21693","article-title":"Brain and other central nervous system tumor statistics, 2021","volume":"71","author":"Miller","year":"2021","journal-title":"CA Cancer J Clin."},{"key":"2024010518031104400_CIT0006","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/noac202","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2015\u20132019","volume":"24","author":"Ostrom","year":"2022","journal-title":"Neuro-Oncol."},{"issue":"5","key":"2024010518031104400_CIT0007","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1474-4422(07)70103-5","article-title":"Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management","volume":"6","author":"van Breemen","year":"2007","journal-title":"Lancet Neurol."},{"issue":"9","key":"2024010518031104400_CIT0008","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s00415-009-5156-9","article-title":"Efficacy of anti-epileptic drugs in patients with gliomas and seizures","volume":"256","author":"van Breemen","year":"2009","journal-title":"J Neurol."},{"issue":"6","key":"2024010518031104400_CIT0009","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/00019052-199612000-00005","article-title":"Epilepsy in patients with central nervous system tumors","volume":"9","author":"Villemure","year":"1996","journal-title":"Curr Opin Neurol."},{"issue":"December","key":"2024010518031104400_CIT0010","doi-asserted-by":"crossref","first-page":"108359","DOI":"10.1016\/j.yebeh.2021.108359","article-title":"Antiepileptic drug management in pediatric patients with brain tumor-related epilepsy","volume":"125","author":"Malbari","year":"2021","journal-title":"Epilepsy Behav."},{"issue":"3","key":"2024010518031104400_CIT0011","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1177\/0883073812445786","article-title":"Seizures as the clinical presenting symptom in children with brain tumors","volume":"28","author":"Fattal-Valevski","year":"2013","journal-title":"J Child Neurol."},{"issue":"November","key":"2024010518031104400_CIT0012","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.eplepsyres.2018.08.007","article-title":"Seizure characteristics are related to tumor pathology in children with brain tumors","volume":"147","author":"Tsai","year":"2018","journal-title":"Epilepsy Res."},{"issue":"4","key":"2024010518031104400_CIT0013","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia."},{"issue":"16","key":"2024010518031104400_CIT0014","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1212\/WNL.0000000000001487","article-title":"Evidence-based guideline: management of an unprovoked first seizure in adults","volume":"84","author":"Krumholz","year":"2015","journal-title":"Neurology."},{"issue":"4","key":"2024010518031104400_CIT0015","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia."},{"issue":"1","key":"2024010518031104400_CIT0016","doi-asserted-by":"crossref","first-page":"13674","DOI":"10.1038\/s41598-020-70754-z","article-title":"Early postoperative seizures (EPS) in patients undergoing brain tumour surgery","volume":"10","author":"Ersoy","year":"2020","journal-title":"Sci Rep."},{"issue":"April","key":"2024010518031104400_CIT0017","doi-asserted-by":"crossref","first-page":"881874","DOI":"10.3389\/fsurg.2022.881874","article-title":"The occurrence and relationship of postoperative seizure and de novo epilepsy after craniotomy surgery: a retrospective single-center cohort study","volume":"9","author":"Horiuchi","year":"2022","journal-title":"Front Surg"},{"issue":"December","key":"2024010518031104400_CIT0018","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/j.wneu.2020.08.036","article-title":"Long-term epilepsy-associated tumors (LEATs): a single-center, retrospective series and review of literature on factors affecting the seizure outcome","volume":"144","author":"Mehrotra","year":"2020","journal-title":"World Neurosurg"},{"issue":"2","key":"2024010518031104400_CIT0019","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/0885066615619582","article-title":"Neurologic emergencies in the patients with cancer","volume":"32","author":"Lin","year":"2017","journal-title":"J Intensive Care Med."},{"issue":"6","key":"2024010518031104400_CIT0020","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/ana.410200609","article-title":"Structural determinants of electroencephalographic findings in acute hemispheric lesions","volume":"20","author":"Schaul","year":"1986","journal-title":"Ann Neurol."},{"issue":"11","key":"2024010518031104400_CIT0021","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1007\/s00381-015-2842-z","article-title":"Signs and symptoms of pediatric brain tumors and diagnostic value of preoperative EEG","volume":"31","author":"Preu\u00df","year":"2015","journal-title":"Childs Nerv Syst."},{"issue":"6","key":"2024010518031104400_CIT0022","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/WNP.0000000000000950","article-title":"Minimum technical requirements for performing ambulatory EEG","volume":"39","author":"Tatum","year":"2022","journal-title":"J Clin Neurophysiol."},{"issue":"1","key":"2024010518031104400_CIT0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/WNP.0000000000000806","article-title":"American Clinical Neurophysiology Society\u2019s standardized critical care EEG terminology: 2021 version","volume":"38","author":"Hirsch","year":"2021","journal-title":"J Clin Neurophysiol."},{"issue":"4","key":"2024010518031104400_CIT0024","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/WNP.0b013e31829ddcdb","article-title":"Spectrum of nonconvulsive status epilepticus in patients with cancer","volume":"30","author":"Spindler","year":"2013","journal-title":"J Clin Neurophysiol."},{"issue":"3","key":"2024010518031104400_CIT0025","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1001\/archneur.61.3.362","article-title":"Nonconvulsive status epilepticus in patients with cancer: imaging abnormalities","volume":"61","author":"Hormigo","year":"2004","journal-title":"Arch Neurol."},{"issue":"5","key":"2024010518031104400_CIT0026","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1528-1157.1987.tb03683.x","article-title":"Transient focal abnormalities of neuroimaging studies during focal status epilepticus","volume":"28","author":"Kramer","year":"1987","journal-title":"Epilepsia."},{"issue":"2","key":"2024010518031104400_CIT0027","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/088307389100600209","article-title":"Transient magnetic resonance imaging abnormalities during partial status epilepticus","volume":"6","author":"Riela","year":"1991","journal-title":"J Child Neurol."},{"issue":"12","key":"2024010518031104400_CIT0028","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.3390\/diagnostics10121049","article-title":"Molecular imaging of brain tumor-associated epilepsy","volume":"10","author":"Juh\u00e1sz","year":"2020","journal-title":"Diagn."},{"issue":"3","key":"2024010518031104400_CIT0029","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1007\/s00259-018-4207-9","article-title":"Joint EANM\/EANO\/RANO practice guidelines\/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0","volume":"46","author":"Law","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging."},{"issue":"1","key":"2024010518031104400_CIT0030","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2967\/jnumed.116.176610","article-title":"Epileptic activity increases cerebral amino acid transport assessed by 18F-fluoroethyl-l-tyrosine amino acid PET: a potential brain tumor mimic","volume":"58","author":"Hutterer","year":"2017","journal-title":"J Nucl Med."},{"issue":"February","key":"2024010518031104400_CIT0031","doi-asserted-by":"crossref","first-page":"104676","DOI":"10.1016\/j.nbd.2019.104676","article-title":"Ex vivo multi-electrode analysis reveals spatiotemporal dynamics of ictal behavior at the infiltrated margin of glioma","volume":"134","author":"Gill","year":"2020","journal-title":"Neurobiol Dis."},{"issue":"9","key":"2024010518031104400_CIT0032","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/nm0901-1010","article-title":"Glutamate release promotes growth of malignant gliomas","volume":"7","author":"Takano","year":"2001","journal-title":"Nat Med."},{"issue":"10","key":"2024010518031104400_CIT0033","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nm.2453","article-title":"Glutamate release by primary brain tumors induces epileptic activity","volume":"17","author":"Buckingham","year":"2011","journal-title":"Nat Med."},{"issue":"17","key":"2024010518031104400_CIT0034","first-page":"4383","article-title":"Glioma cells release excitotoxic concentrations of glutamate","volume":"59","author":"Ye","year":"1999","journal-title":"Cancer Res."},{"issue":"24","key":"2024010518031104400_CIT0035","doi-asserted-by":"crossref","first-page":"10767","DOI":"10.1523\/JNEUROSCI.19-24-10767.1999","article-title":"Compromised glutamate transport in human glioma cells: reduction-mislocalization of sodium-dependent glutamate transporters and enhanced activity of cystine-glutamate exchange","volume":"19","author":"Ye","year":"1999","journal-title":"J Neurosci."},{"issue":"9","key":"2024010518031104400_CIT0036","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1212\/WNL.0b013e318266fa89","article-title":"Glutamate is associated with a higher risk of seizures in patients with gliomas","volume":"79","author":"Yuen","year":"2012","journal-title":"Neurology."},{"issue":"9","key":"2024010518031104400_CIT0037","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/nm746","article-title":"Blockage of Ca(2+)-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells","volume":"8","author":"Ishiuchi","year":"2002","journal-title":"Nat Med."},{"issue":"10","key":"2024010518031104400_CIT0038","doi-asserted-by":"crossref","first-page":"e47846","DOI":"10.1371\/journal.pone.0047846","article-title":"Overexpression of calcium-permeable glutamate receptors in glioblastoma derived brain tumor initiating cells","volume":"7","author":"Oh","year":"2012","journal-title":"PLoS One."},{"issue":"6","key":"2024010518031104400_CIT0039","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nn.2806","article-title":"NMDA receptor activity downregulates KCC2 resulting in depolarizing GABAA receptor mediated currents","volume":"14","author":"Lee","year":"2011","journal-title":"Nat Neurosci."},{"issue":"244","key":"2024010518031104400_CIT0040","doi-asserted-by":"crossref","first-page":"244ra89","DOI":"10.1126\/scitranslmed.3008065","article-title":"Cortical GABAergic excitation contributes to epileptic activities around human glioma","volume":"6","author":"Pallud","year":"2014","journal-title":"Sci Transl Med."},{"issue":"October","key":"2024010518031104400_CIT0041","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.eplepsyres.2016.07.010","article-title":"Compromised GABAergic inhibition contributes to tumor-associated epilepsy","volume":"126","author":"MacKenzie","year":"2016","journal-title":"Epilepsy Res."},{"issue":"7673","key":"2024010518031104400_CIT0042","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nature24014","article-title":"Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma","volume":"549","author":"Venkatesh","year":"2017","journal-title":"Nature."},{"issue":"7775","key":"2024010518031104400_CIT0043","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41586-019-1563-y","article-title":"Electrical and synaptic integration of glioma into neural circuits","volume":"573","author":"Venkatesh","year":"2019","journal-title":"Nature."},{"issue":"7775","key":"2024010518031104400_CIT0044","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41586-019-1564-x","article-title":"Glutamatergic synaptic input to glioma cells drives brain tumour progression","volume":"573","author":"Venkataramani","year":"2019","journal-title":"Nature."},{"issue":"19","key":"2024010518031104400_CIT0045","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1212\/WNL.0000000000003911","article-title":"Mutant IDH1 and seizures in patients with glioma","volume":"88","author":"Chen","year":"2017","journal-title":"Neurology."},{"issue":"September","key":"2024010518031104400_CIT0046","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jocn.2015.11.030","article-title":"An analysis of 170 glioma patients and systematic review to investigate the association between IDH-1 mutations and preoperative glioma-related epilepsy","volume":"31","author":"Yang","year":"2016","journal-title":"J Clin Neurosci."},{"issue":"9","key":"2024010518031104400_CIT0047","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1093\/neuonc\/noac003","article-title":"IDH-mutated gliomas promote epileptogenesis through d-2-hydroxyglutarate-dependent mTOR hyperactivation","volume":"24","author":"Mortazavi","year":"2022","journal-title":"Neuro-Oncol."},{"issue":"7793","key":"2024010518031104400_CIT0048","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41586-020-1952-2","article-title":"PIK3CA variants selectively initiate brain hyperactivity during gliomagenesis","volume":"578","author":"Yu","year":"2020","journal-title":"Nature."},{"issue":"September","key":"2024010518031104400_CIT0049","doi-asserted-by":"crossref","first-page":"106681","DOI":"10.1016\/j.eplepsyres.2021.106681","article-title":"Effect of PIK3CA variants on glioma-related epilepsy and response to treatment","volume":"175","author":"Tobochnik","year":"2021","journal-title":"Epilepsy Res."},{"issue":"11","key":"2024010518031104400_CIT0050","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1038\/s41591-018-0172-x","article-title":"BRAF somatic mutation contributes to intrinsic epileptogenicity in pediatric brain tumors","volume":"24","author":"Koh","year":"2018","journal-title":"Nat Med."},{"issue":"1","key":"2024010518031104400_CIT0051","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/bpa.12081","article-title":"BRAF V600E mutation is associated with mTOR signaling activation in glioneuronal tumors","volume":"24","author":"Prabowo","year":"2013","journal-title":"Brain Pathol."},{"issue":"6","key":"2024010518031104400_CIT0052","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.3171\/2015.4.JNS142742","article-title":"Seizures in supratentorial meningioma: a systematic review and meta-analysis","volume":"124","author":"Englot","year":"2016","journal-title":"J Neurosurg."},{"issue":"3","key":"2024010518031104400_CIT0053","first-page":"1","article-title":"Clinical and genomic factors associated with seizures in meningiomas","volume":"135","author":"Gupte","year":"2020","journal-title":"J Neurosurg."},{"issue":"11","key":"2024010518031104400_CIT0054","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1158\/0008-5472.CAN-16-2289","article-title":"GAD1 upregulation programs aggressive features of cancer cell metabolism in the brain metastatic microenvironment","volume":"77","author":"Schnepp","year":"2017","journal-title":"Cancer Res."},{"issue":"6","key":"2024010518031104400_CIT0055","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nrclinonc.2011.58","article-title":"The biology of brain metastases\u2014translation to new therapies","volume":"8","author":"Eichler","year":"2011","journal-title":"Nat Rev Clin Oncol."},{"issue":"4","key":"2024010518031104400_CIT0056","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/neuonc\/not170","article-title":"Levetiracetam and pregabalin for antiepileptic monotherapy in patients with primary brain tumors. A phase II randomized study","volume":"16","author":"Rossetti","year":"2014","journal-title":"Neuro-Oncol."},{"issue":"2","key":"2024010518031104400_CIT0057","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3390\/brainsci13020326","article-title":"Perampanel in brain tumor-related epilepsy: a systematic review","volume":"13","author":"Tabaee Damavandi","year":"2023","journal-title":"Brain Sci"},{"issue":"12","key":"2024010518031104400_CIT0058","first-page":"90","article-title":"Significant reduction of seizure incidence and increase of benzodiazepine receptor density after interstitial radiosurgery in low-grade gliomas","volume":"68","author":"Warnke","year":"1997","journal-title":"Acta Neurochir Suppl."},{"issue":"5","key":"2024010518031104400_CIT0059","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/nop\/npab030","article-title":"Efficacy of antiepileptic drugs in glioma patients with epilepsy: a systematic review","volume":"8","author":"de Bruin","year":"2021","journal-title":"Neuro-Oncol Pract."},{"issue":"2","key":"2024010518031104400_CIT0060","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/neuonc\/nor205","article-title":"Seizure characteristics and outcomes in 508 Chinese adult patients undergoing primary resection of low-grade gliomas: a clinicopathological study","volume":"14","author":"You","year":"2012","journal-title":"Neuro-Oncol."},{"issue":"1","key":"2024010518031104400_CIT0061","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/epi.17464","article-title":"Italian League Against Epilepsy Brain Tumor-Related Epilepsy Study Group. First-line levetiracetam versus enzyme-inducing antiseizure medication in glioma patients with epilepsy","volume":"64","author":"van der Meer","year":"2023","journal-title":"Epilepsia."},{"issue":"4","key":"2024010518031104400_CIT0062","first-page":"CD010224","article-title":"Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child","volume":"2017","author":"Weston","year":"2016","journal-title":"Cochrane Database Syst Rev."},{"issue":"1","key":"2024010518031104400_CIT0063","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11060-007-9430-3","article-title":"Outcome and tolerability of topiramate in brain tumor associated epilepsy","volume":"86","author":"Maschio","year":"2008","journal-title":"J Neurooncol."},{"issue":"3","key":"2024010518031104400_CIT0064","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/WNF.0000000000000218","article-title":"Zonisamide in brain tumor-related epilepsy: an observational pilot study","volume":"40","author":"Maschio","year":"2017","journal-title":"Clin Neuropharmacol."},{"issue":"1","key":"2024010518031104400_CIT0065","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1756-9966-28-60","article-title":"The role side effects play in the choice of antiepileptic therapy in brain tumor-related epilepsy: a comparative study on traditional antiepileptic drugs versus oxcarbazepine","volume":"28","author":"Maschio","year":"2009","journal-title":"J Exp Clin Cancer Res CR."},{"issue":"3","key":"2024010518031104400_CIT0066","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s11060-011-0689-z","article-title":"Oxcarbazepine monotherapy in patients with brain tumor-related epilepsy: open-label pilot study for assessing the efficacy, tolerability and impact on quality of life","volume":"106","author":"Maschio","year":"2012","journal-title":"J Neurooncol."},{"issue":"2","key":"2024010518031104400_CIT0067","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1017\/S0317167100038853","article-title":"Add-on gabapentin for refractory seizures in patients with brain tumours","volume":"23","author":"Perry","year":"1996","journal-title":"Can J Neurol Sci."},{"issue":"December","key":"2024010518031104400_CIT0068","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.yebeh.2016.09.033","article-title":"NEOPLASM study: real-life use of lacosamide in patients with brain tumor-related epilepsy","volume":"65","author":"Villanueva","year":"2016","journal-title":"Epilepsy Behav."},{"issue":"3","key":"2024010518031104400_CIT0069","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s11060-022-03998-6","article-title":"Lacosamide in monotherapy in BTRE (brain tumor-related epilepsy): results from an Italian multicenter retrospective study","volume":"157","author":"Mo","year":"2022","journal-title":"J Neurooncol."},{"issue":"9","key":"2024010518031104400_CIT0070","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1080\/00207454.2020.1759590","article-title":"Eslicarbazepine in patients with brain tumor-related epilepsy: a single-center experience","volume":"131","author":"Zoccarato","year":"2021","journal-title":"Int J Neurosci."},{"issue":"August","key":"2024010518031104400_CIT0071","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3389\/fneur.2020.00813","article-title":"Effect of brivaracetam on efficacy and tolerability in patients with brain tumor-related epilepsy: a retrospective multicenter study","volume":"11","author":"Maschio","year":"2020","journal-title":"Front Neurol."},{"issue":"2","key":"2024010518031104400_CIT0072","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11060-020-03664-9","article-title":"Efficacy of clobazam as add-on therapy in brain tumor-related epilepsy","volume":"151","author":"Brahmbhatt","year":"2021","journal-title":"J Neurooncol."},{"issue":"1","key":"2024010518031104400_CIT0073","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1474-4422(19)30399-0","article-title":"Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial","volume":"19","author":"Krauss","year":"2020","journal-title":"Lancet Neurol."},{"issue":"5","key":"2024010518031104400_CIT0074","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00415-017-8463-6","article-title":"Brain tumor location influences the onset of acute psychiatric adverse events of levetiracetam therapy: an observational study","volume":"264","author":"Belcastro","year":"2017","journal-title":"J Neurol."},{"issue":"3","key":"2024010518031104400_CIT0075","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/head.12781","article-title":"The use of antiepileptics in migraine prophylaxis","volume":"56","author":"Bagnato","year":"2016","journal-title":"Headache."},{"issue":"6","key":"2024010518031104400_CIT0076","first-page":"CD010611","article-title":"Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults","volume":"2013","author":"Linde","year":"2013","journal-title":"Cochrane Database Syst Rev."},{"issue":"2","key":"2024010518031104400_CIT0077","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1212\/WNL.0000000000007696","article-title":"Risks of 23 specific malformations associated with prenatal exposure to 10 antiepileptic drugs","volume":"93","author":"Bloti\u00e8re","year":"2019","journal-title":"Neurology."},{"issue":"1","key":"2024010518031104400_CIT0078","first-page":"34","article-title":"Epilepsy and pregnancy","volume":"28","author":"Li","year":"2022","journal-title":"Continuum."},{"issue":"4","key":"2024010518031104400_CIT0079","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/cts.13204","article-title":"Effect of cenobamate on the single-dose pharmacokinetics of multiple cytochrome P450 probes using a cocktail approach in healthy subjects","volume":"15","author":"Greene","year":"2022","journal-title":"Clin Transl Sci."},{"issue":"3","key":"2024010518031104400_CIT0080","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1528-1167.2007.00924.x","article-title":"A comparative pharmacokinetic study in healthy volunteers of the effect of carbamazepine and oxcarbazepine on cyp3a4","volume":"48","author":"Andreasen","year":"2007","journal-title":"Epilepsia."},{"issue":"1-2","key":"2024010518031104400_CIT0081","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.eplepsyres.2013.04.009","article-title":"Effect of repeated administration of eslicarbazepine acetate on the pharmacokinetics of simvastatin in healthy subjects","volume":"106","author":"Falc\u00e3o","year":"2013","journal-title":"Epilepsy Res."},{"issue":"1","key":"2024010518031104400_CIT0082","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol Ther."},{"key":"2024010518031104400_CIT0083","first-page":"45","article-title":"Chapter 3 - antiepileptic drugs and chemotherapy: potential interactions and impact on treatment of patients with cancer","volume-title":"Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy","author":"Fink","year":"2018","edition":"2"},{"issue":"4","key":"2024010518031104400_CIT0084","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/nop\/npv038","article-title":"Seizures and cancer: drug interactions of anticonvulsants with chemotherapeutic agents, tyrosine kinase inhibitors and glucocorticoids","volume":"3","author":"B\u00e9nit","year":"2016","journal-title":"Neuro-Oncol Pract."},{"issue":"9","key":"2024010518031104400_CIT0085","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/s00277-020-04186-0","article-title":"Drug-drug interactions of newly approved small molecule inhibitors for acute myeloid leukemia","volume":"99","author":"Meg\u00edas-Vericat","year":"2020","journal-title":"Ann Hematol."},{"issue":"10","key":"2024010518031104400_CIT0086","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1136\/jnnp.47.10.1087","article-title":"Phenytoin impairs the bioavailability of dexamethasone in neurological and neurosurgical patients","volume":"47","author":"Chalk","year":"1984","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"12","key":"2024010518031104400_CIT0087","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1212\/WNL.0b013e31822f02e1","article-title":"Prolonged survival with valproic acid use in the EORTC\/NCIC temozolomide trial for glioblastoma","volume":"77","author":"Weller","year":"2011","journal-title":"Neurology."},{"issue":"7","key":"2024010518031104400_CIT0088","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/epi.13777","article-title":"Carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy","volume":"58","author":"Berghuis","year":"2017","journal-title":"Epilepsia."},{"issue":"March","key":"2024010518031104400_CIT0089","doi-asserted-by":"crossref","first-page":"120584","DOI":"10.1016\/j.jns.2023.120584","article-title":"Epilepsy and brain tumors: two sides of the same coin","volume":"446","author":"Aronica","year":"2023","journal-title":"J Neurol Sci."},{"issue":"10","key":"2024010518031104400_CIT0090","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med."},{"issue":"3","key":"2024010518031104400_CIT0091","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s11060-016-2054-8","article-title":"Valproic acid, compared to other antiepileptic drugs, is associated with improved overall and progression-free survival in glioblastoma but worse outcome in grade II\/III gliomas treated with temozolomide","volume":"127","author":"Redjal","year":"2016","journal-title":"J Neurooncol."},{"issue":"5","key":"2024010518031104400_CIT0092","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ijrobp.2015.04.038","article-title":"A phase 2 study of concurrent radiation therapy, temozolomide, and the histone deacetylase inhibitor valproic acid for patients with glioblastoma","volume":"92","author":"Krauze","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"7","key":"2024010518031104400_CIT0093","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1200\/JCO.2015.63.6563","article-title":"Does valproic acid or levetiracetam improve survival in glioblastoma? A pooled analysis of prospective clinical trials in newly diagnosed glioblastoma","volume":"34","author":"Happold","year":"2016","journal-title":"J Clin Oncol."},{"issue":"3","key":"2024010518031104400_CIT0094","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11060-016-2191-0","article-title":"Does the choice of antiepileptic drug affect survival in glioblastoma patients","volume":"129","author":"Knudsen-Baas","year":"2016","journal-title":"J Neurooncol."},{"issue":"15","key":"2024010518031104400_CIT0095","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.3390\/cancers13153770","article-title":"How about levetiracetam in glioblastoma? An institutional experience and meta-analysis","volume":"13","author":"Jabbarli","year":"2021","journal-title":"Cancers"},{"issue":"2","key":"2024010518031104400_CIT0096","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1212\/WNL.0000000000013005","article-title":"Effect of levetiracetam use duration on overall survival of isocitrate dehydrogenase wild-type glioblastoma in adults: an observational study","volume":"98","author":"Pallud","year":"2022","journal-title":"Neurology."},{"issue":"17","key":"2024010518031104400_CIT0097","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1002\/cncr.29439","article-title":"Survival benefit of levetiracetam in patients treated with concomitant chemoradiotherapy and adjuvant chemotherapy with temozolomide for glioblastoma multiforme","volume":"121","author":"Kim","year":"2015","journal-title":"Cancer."},{"issue":"2","key":"2024010518031104400_CIT0098","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/cam4.4454","article-title":"Levetiracetam as a sensitizer of concurrent chemoradiotherapy in newly diagnosed glioblastoma: an open-label phase 2 study","volume":"11","author":"Hwang","year":"2022","journal-title":"Cancer Med"},{"issue":"2","key":"2024010518031104400_CIT0099","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11060-021-03940-2","article-title":"The effect of levetiracetam treatment on survival in patients with glioblastoma: a systematic review and meta-analysis","volume":"156","author":"Chen","year":"2022","journal-title":"J Neurooncol."},{"issue":"1","key":"2024010518031104400_CIT0100","doi-asserted-by":"crossref","first-page":"vdac112","DOI":"10.1093\/noajnl\/vdac112","article-title":"Associations of levetiracetam use with the safety and tolerability profile of chemoradiotherapy for patients with newly diagnosed glioblastoma","volume":"4","author":"Seystahl","year":"2022","journal-title":"Neuro-Oncol Adv."},{"issue":"January","key":"2024010518031104400_CIT0101","doi-asserted-by":"crossref","first-page":"134629","DOI":"10.1016\/j.neulet.2019.134629","article-title":"Perampanel attenuates epileptiform phenotype in C6 glioma","volume":"715","author":"Mayer","year":"2020","journal-title":"Neurosci Lett."},{"issue":"7","key":"2024010518031104400_CIT0102","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.21873\/anticanres.12737","article-title":"Seizures and tumor progression in glioma patients with uncontrollable epilepsy treated with perampanel","volume":"38","author":"Izumoto","year":"2018","journal-title":"Anticancer Res."},{"issue":"25","key":"2024010518031104400_CIT0103","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1200\/JCO.2008.21.6895","article-title":"Talampanel with standard radiation and temozolomide in patients with newly diagnosed glioblastoma: a multicenter phase II trial","volume":"27","author":"Grossman","year":"2009","journal-title":"J Clin Oncol."},{"issue":"7","key":"2024010518031104400_CIT0104","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/cncr.24957","article-title":"Phase 2 trial of talampanel, a glutamate receptor inhibitor, for adults with recurrent malignant gliomas","volume":"116","author":"Iwamoto","year":"2010","journal-title":"Cancer."},{"issue":"11","key":"2024010518031104400_CIT0105","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1093\/neuonc\/noab152","article-title":"SNO and EANO practice guideline update: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors","volume":"23","author":"Walbert","year":"2021","journal-title":"Neuro-Oncol."},{"issue":"2","key":"2024010518031104400_CIT0106","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11060-004-6912-4","article-title":"Results of a survey of neurosurgical practice patterns regarding the prophylactic use of anti-epilepsy drugs in patients with brain tumors","volume":"74","author":"Siomin","year":"2005","journal-title":"J Neurooncol."},{"issue":"6","key":"2024010518031104400_CIT0107","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.3171\/2016.4.JNS16245","article-title":"Prophylactic antiepileptic drug administration following brain tumor resection: results of a recent AANS\/CNS Section on Tumors survey","volume":"126","author":"Dewan","year":"2017","journal-title":"J Neurosurg."},{"issue":"4","key":"2024010518031104400_CIT0108","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.3171\/2017.10.JNS172236","article-title":"Effectiveness of perioperative antiepileptic drug prophylaxis for early and late seizures following oncologic neurosurgery: a meta-analysis","volume":"130","author":"Joiner","year":"2018","journal-title":"J Neurosurg."},{"issue":"2","key":"2024010518031104400_CIT0109","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/nop\/npab059","article-title":"Prescription preferences of antiepileptic drugs in brain tumor patients: an international survey among EANO members","volume":"9","author":"van der Meer","year":"2022","journal-title":"Neuro-Oncol Pract."},{"issue":"10","key":"2024010518031104400_CIT0110","doi-asserted-by":"crossref","first-page":"e999","DOI":"10.1212\/WNL.0000000000200807","article-title":"Effectiveness of antiseizure medication duotherapies in patients with glioma: a multicenter observational cohort study","volume":"99","author":"van der Meer","year":"2022","journal-title":"Neurology."},{"issue":"1","key":"2024010518031104400_CIT0111","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11060-021-03800-z","article-title":"The effectiveness of antiepileptic drug treatment in glioma patients: lamotrigine versus lacosamide","volume":"154","author":"van Opijnen","year":"2021","journal-title":"J Neurooncol."},{"issue":"4","key":"2024010518031104400_CIT0112","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/epi.16486","article-title":"Effectiveness and tolerability of lacosamide as add-on therapy in patients with brain tumor-related epilepsy: results from a prospective, noninterventional study in European clinical practice (VIBES)","volume":"61","author":"Rud\u00e0","year":"2020","journal-title":"Epilepsia."},{"issue":"June","key":"2024010518031104400_CIT0113","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3389\/fneur.2020.00592","article-title":"Perampanel confirms to be effective and well-tolerated as an add-on treatment in patients with brain tumor-related epilepsy (PERADET Study)","volume":"11","author":"Coppola","year":"2020","journal-title":"Front Neurol."},{"issue":"6","key":"2024010518031104400_CIT0114","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia."},{"issue":"1","key":"2024010518031104400_CIT0115","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/nop\/npaa054","article-title":"Predictors of early, recurrent, and intractable seizures in low-grade glioma","volume":"8","author":"Jo","year":"2021","journal-title":"Neuro-Oncol Pract."},{"issue":"14","key":"2024010518031104400_CIT0116","doi-asserted-by":"crossref","first-page":"e1488","DOI":"10.1212\/WNL.0000000000206852","article-title":"Effectiveness of antiseizure medication triple therapy in patients with glioma with refractory epilepsy: an observational cohort study","volume":"100","author":"van der Meer","year":"2023","journal-title":"Neurology."},{"issue":"1","key":"2024010518031104400_CIT0117","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/ane.12809","article-title":"Outcome of cancer-related seizures in patients treated with lacosamide","volume":"137","author":"Toledo","year":"2018","journal-title":"Acta Neurol Scand."},{"issue":"11","key":"2024010518031104400_CIT0118","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/neuonc\/noac172","article-title":"Improved seizure control in patients with recurrent glioblastoma treated with bevacizumab","volume":"24","author":"Hertler","year":"2022","journal-title":"Neuro-Oncol."},{"issue":"7","key":"2024010518031104400_CIT0119","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/j.1528-1167.2006.00597.x","article-title":"Temozolomide treatment of refractory epilepsy in a patient with an oligodendroglioma","volume":"47","author":"Ngo","year":"2006","journal-title":"Epilepsia."},{"issue":"7","key":"2024010518031104400_CIT0120","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1089\/jpm.2020.0414","article-title":"Subcutaneous levetiracetam for the management of seizures at the end of life: an audit and updated literature review","volume":"24","author":"Sutherland","year":"2021","journal-title":"J Palliat Med."},{"issue":"4","key":"2024010518031104400_CIT0121","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1007\/s00520-015-2930-3","article-title":"Antiepileptic drug treatment in the end-of-life phase of glioma patients: a feasibility study","volume":"24","author":"Koekkoek","year":"2016","journal-title":"Support Care Cancer."},{"issue":"3","key":"2024010518031104400_CIT0122","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/NRL.0b013e318217368e","article-title":"Timing of antiepileptic drug withdrawal in adult epilepsy patients after neocortical surgical resection: a critically appraised topic","volume":"17","author":"Ziemba","year":"2011","journal-title":"Neurologist"},{"issue":"2","key":"2024010518031104400_CIT0123","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3171\/2011.3.JNS1153","article-title":"Predictors of seizure freedom after resection of supratentorial low-grade gliomas: a review","volume":"115","author":"Englot","year":"2011","journal-title":"J Neurosurg."},{"issue":"1","key":"2024010518031104400_CIT0124","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/brainsci13010024","article-title":"Long-term seizure outcomes and predictors in patients with dysembryoplastic neuroepithelial tumors associated with epilepsy","volume":"13","author":"Zhang","year":"2022","journal-title":"Brain Sci"},{"issue":"9","key":"2024010518031104400_CIT0125","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S1474-4422(20)30220-9","article-title":"Seizure outcome and use of antiepileptic drugs after epilepsy surgery according to histopathological diagnosis: a retrospective multicentre cohort study","volume":"19","author":"Lamberink","year":"2020","journal-title":"Lancet Neurol."},{"issue":"8","key":"2024010518031104400_CIT0126","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s10072-019-03855-x","article-title":"Correlation between EEG during AED withdrawal and epilepsy recurrence: a meta-analysis","volume":"40","author":"Yao","year":"2019","journal-title":"Neurol Sci."},{"issue":"3","key":"2024010518031104400_CIT0127","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s11060-019-03117-y","article-title":"Withdrawal of antiepileptic drugs in patients with low grade and anaplastic glioma after long-term seizure freedom: a prospective observational study","volume":"142","author":"Kerkhof","year":"2019","journal-title":"J Neurooncol."},{"issue":"3","key":"2024010518031104400_CIT0128","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s11060-011-0779-y","article-title":"Outcomes after discontinuation of antiepileptic drugs after surgery in patients with low grade brain tumors and meningiomas","volume":"107","author":"Das","year":"2012","journal-title":"J Neurooncol."},{"issue":"1","key":"2024010518031104400_CIT0129","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1684\/epd.2021.1376","article-title":"Acute symptomatic seizures: an educational, evidence-based review","volume":"24","author":"Mauritz","year":"2022","journal-title":"Epileptic Disord."},{"issue":"12","key":"2024010518031104400_CIT0130","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/S1474-4422(21)00300-8","article-title":"Neuromodulation in epilepsy: state-of-the-art approved therapies","volume":"20","author":"Ryvlin","year":"2021","journal-title":"Lancet Neurol."},{"issue":"3","key":"2024010518031104400_CIT0131","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1227\/NEU.0000000000001165","article-title":"Rates and predictors of seizure freedom with vagus nerve stimulation for intractable epilepsy","volume":"79","author":"Englot","year":"2016","journal-title":"Neurosurgery."},{"issue":"9","key":"2024010518031104400_CIT0132","doi-asserted-by":"crossref","first-page":"e1244","DOI":"10.1212\/WNL.0000000000010154","article-title":"Nine-year prospective efficacy and safety of brain-responsive neurostimulation for focal epilepsy","volume":"95","author":"Nair","year":"2020","journal-title":"Neurology."},{"issue":"10","key":"2024010518031104400_CIT0133","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1212\/WNL.0000000000001334","article-title":"Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy","volume":"84","author":"Salanova","year":"2015","journal-title":"Neurology."},{"issue":"1","key":"2024010518031104400_CIT0134","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1227\/neu.0000000000002403","article-title":"Risk of tract seeding following laser interstitial thermal therapy for brain tumors","volume":"93","author":"Haskell-Mendoza","year":"2022","journal-title":"Neurosurgery."},{"issue":"8","key":"2024010518031104400_CIT0135","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.seizure.2013.04.017","article-title":"Efficacy of vagus nerve stimulation as a treatment for medically intractable epilepsy in brain tumor patients. A case-controlled study using the VNS therapy Patient Outcome Registry","volume":"22","author":"Patel","year":"2013","journal-title":"Seizure J Br Epilepsy Assoc."},{"issue":"2","key":"2024010518031104400_CIT0136","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3171\/2013.3.JNS121890","article-title":"Efficacy of vagus nerve stimulation in brain tumor-associated intractable epilepsy and the importance of tumor stability","volume":"119","author":"Patel","year":"2013","journal-title":"J Neurosurg."},{"issue":"2","key":"2024010518031104400_CIT0137","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/epi4.12481","article-title":"Brain-Responsive Neurostimulation for the treatment of adults with epilepsy in tuberous sclerosis complex: a case series","volume":"6","author":"McDermott","year":"2021","journal-title":"Epilepsia Open"},{"issue":"3","key":"2024010518031104400_CIT0138","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/neuros\/nyy342","article-title":"The impact of intraoperative electrocorticography on seizure outcome after resection of pediatric brain tumors: a cohort study","volume":"85","author":"Robertson","year":"2019","journal-title":"Neurosurgery."},{"issue":"January","key":"2024010518031104400_CIT0139","doi-asserted-by":"crossref","first-page":"107054","DOI":"10.1016\/j.clineuro.2021.107054","article-title":"The utility of intraoperative ECoG in tumor-related epilepsy: systematic review","volume":"212","author":"Zhu","year":"2022","journal-title":"Clin Neurol Neurosurg."},{"issue":"2","key":"2024010518031104400_CIT0140","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/epi.17472","article-title":"Clinical utility of intraoperative electrocorticography for epilepsy surgery: a systematic review and meta-analysis","volume":"64","author":"Goel","year":"2023","journal-title":"Epilepsia."},{"issue":"4","key":"2024010518031104400_CIT0141","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/epi.16845","article-title":"Can we use intraoperative high-frequency oscillations to guide tumor-related epilepsy surgery","volume":"62","author":"van Klink","year":"2021","journal-title":"Epilepsia."},{"issue":"3","key":"2024010518031104400_CIT0142","doi-asserted-by":"crossref","first-page":"840","DOI":"10.3171\/2016.11.JNS161296","article-title":"Surgery guided with intraoperative electrocorticography in patients with low-grade glioma and refractory seizures","volume":"128","author":"Yao","year":"2018","journal-title":"J Neurosurg."},{"issue":"1","key":"2024010518031104400_CIT0143","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1227\/neu.0000000000002182","article-title":"Electrocorticography-guided resection enhances postoperative seizure freedom in low-grade tumor-associated epilepsy: a systematic review and meta-analysis","volume":"92","author":"Warsi","year":"2023","journal-title":"Neurosurgery."},{"issue":"13","key":"2024010518031104400_CIT0144","doi-asserted-by":"crossref","first-page":"e1119","DOI":"10.1212\/WNL.0000000000005216","article-title":"High-frequency oscillations in awake patients undergoing brain tumor-related epilepsy surgery","volume":"90","author":"Feyissa","year":"2018","journal-title":"Neurology."},{"issue":"4","key":"2024010518031104400_CIT0145","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.clinph.2019.12.416","article-title":"Detection of after-discharges during intraoperative functional brain mapping in awake brain tumor surgery using a novel high-density circular grid","volume":"131","author":"Tatum","year":"2020","journal-title":"Clin Neurophysiol."},{"issue":"7","key":"2024010518031104400_CIT0146","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/neuonc\/nov032","article-title":"Seizure outcome after radiotherapy and chemotherapy in low-grade glioma patients: a systematic review","volume":"17","author":"Koekkoek","year":"2015","journal-title":"Neuro-Oncol."},{"issue":"12","key":"2024010518031104400_CIT0147","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/neuonc\/not109","article-title":"Seizure control following radiotherapy in patients with diffuse gliomas: a retrospective study","volume":"15","author":"Rud\u00e0","year":"2013","journal-title":"Neuro-Oncol."},{"issue":"1-6","key":"2024010518031104400_CIT0148","first-page":"127","article-title":"Epileptogenic cerebral low-grade tumors: effect of interstitial stereotactic irradiation on seizures","volume":"48","author":"Rossi","year":"1985","journal-title":"Appl Neurophysiol"},{"key":"2024010518031104400_CIT0149","first-page":"49","article-title":"Gamma-Knife radiosurgery of mesiotemporal tumour epilepsy observations and long-term results","volume":"84","author":"Schr\u00f6ttner","year":"2002","journal-title":"Acta Neurochir Suppl."},{"issue":"8","key":"2024010518031104400_CIT0150","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1212\/WNL.43.8.1599","article-title":"Effect of cranial irradiation on seizure frequency in adults with low-grade astrocytoma and medically intractable epilepsy","volume":"43","author":"Rogers","year":"1993","journal-title":"Neurology."},{"issue":"9490","key":"2024010518031104400_CIT0151","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0140-6736(05)67070-5","article-title":"Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial","volume":"366","author":"van den Bent","year":"2005","journal-title":"Lancet."},{"issue":"5","key":"2024010518031104400_CIT0152","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/neuonc\/noz172","article-title":"Risk factors for the development of epilepsy in patients with brain metastases","volume":"22","author":"Wolpert","year":"2020","journal-title":"Neuro-Oncol."},{"issue":"2","key":"2024010518031104400_CIT0153","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11940-020-0613-y","article-title":"Epilepsy in brain metastasis: an emerging entity","volume":"22","author":"Rud\u00e0","year":"2020","journal-title":"Curr Treat Options Neurol"},{"issue":"November","key":"2024010518031104400_CIT0154","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.yebeh.2018.09.002","article-title":"Focused review on seizures caused by meningiomas","volume":"88","author":"Baumgarten","year":"2018","journal-title":"Epilepsy Behav."},{"issue":"6","key":"2024010518031104400_CIT0155","doi-asserted-by":"crossref","first-page":"101054","DOI":"10.1016\/j.adro.2022.101054","article-title":"Factors associated with new-onset seizures following stereotactic radiosurgery for newly diagnosed brain metastases","volume":"7","author":"Lerner","year":"2022","journal-title":"Adv Radiat Oncol"},{"issue":"Suppl 4","key":"2024010518031104400_CIT0156","doi-asserted-by":"crossref","first-page":"iv55","DOI":"10.1093\/neuonc\/nos199","article-title":"Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments","volume":"14","author":"Rud\u00e0","year":"2012","journal-title":"Neuro-Oncol."},{"issue":"1","key":"2024010518031104400_CIT0157","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11060-019-03277-x","article-title":"Efficacy of initial temozolomide for high-risk low grade gliomas in a phase II AINO (Italian Association for Neuro-Oncology) study: a post-hoc analysis within molecular subgroups of WHO 2016","volume":"145","author":"Rud\u00e0","year":"2019","journal-title":"J Neurooncol."},{"issue":"5","key":"2024010518031104400_CIT0158","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s00330-015-3934-6","article-title":"Evaluation of low-grade glioma structural changes after chemotherapy using DTI-based histogram analysis and functional diffusion maps","volume":"26","author":"Castellano","year":"2016","journal-title":"Eur Radiol."},{"issue":"1","key":"2024010518031104400_CIT0159","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11060-020-03573-x","article-title":"Temozolomide and seizure outcomes in a randomized clinical trial of elderly glioblastoma patients","volume":"149","author":"Climans","year":"2020","journal-title":"J Neurooncol."},{"issue":"5","key":"2024010518031104400_CIT0160","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/ana.23960","article-title":"Everolimus treatment of refractory epilepsy in tuberous sclerosis complex","volume":"74","author":"Krueger","year":"2013","journal-title":"Ann Neurol."},{"issue":"6","key":"2024010518031104400_CIT0161","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/ana.24523","article-title":"Everolimus for subependymal giant cell astrocytoma: 5-year final analysis","volume":"78","author":"Franz","year":"2015","journal-title":"Ann Neurol."},{"issue":"January","key":"2024010518031104400_CIT0162","doi-asserted-by":"crossref","first-page":"100526","DOI":"10.1016\/j.ebr.2022.100526","article-title":"The IDH1 inhibitor ivosidenib improved seizures in a patient with drug-resistant epilepsy from IDH1 mutant oligodendroglioma","volume":"18","author":"Vo","year":"2022","journal-title":"Epilepsy Behav Rep"},{"issue":"1","key":"2024010518031104400_CIT0163","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/neuonc\/now190","article-title":"Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials","volume":"19","author":"Avila","year":"2017","journal-title":"Neuro-Oncol."},{"issue":"11","key":"2024010518031104400_CIT0164","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1111\/epi.16360","article-title":"Ultra-long-term subcutaneous home monitoring of epilepsy\u2014490 days of EEG from nine patients","volume":"60","author":"Weisdorf","year":"2019","journal-title":"Epilepsia."},{"issue":"8","key":"2024010518031104400_CIT0165","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1111\/epi.17297","article-title":"Automated seizure detection with noninvasive wearable devices: a systematic review and meta-analysis","volume":"63","author":"Naganur","year":"2022","journal-title":"Epilepsia."},{"issue":"1","key":"2024010518031104400_CIT0166","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11060-022-04059-8","article-title":"Early EEG hyperexcitability is associated with decreased survival in newly diagnosed IDH-wildtype glioma","volume":"159","author":"Tobochnik","year":"2022","journal-title":"J Neurooncol."},{"issue":"2","key":"2024010518031104400_CIT0167","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s11060-018-2967-5","article-title":"Oscillatory brain activity associates with neuroligin-3 expression and predicts progression free survival in patients with diffuse glioma","volume":"140","author":"Derks","year":"2018","journal-title":"J Neurooncol."},{"issue":"1","key":"2024010518031104400_CIT0168","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11060-019-03386-7","article-title":"Postoperative oscillatory brain activity as an add-on prognostic marker in diffuse glioma","volume":"147","author":"Belgers","year":"2020","journal-title":"J Neurooncol."},{"issue":"1","key":"2024010518031104400_CIT0169","doi-asserted-by":"crossref","first-page":"18990","DOI":"10.1038\/s41598-021-97818-y","article-title":"Non-invasively measured brain activity and radiological progression in diffuse glioma","volume":"11","author":"Numan","year":"2021","journal-title":"Sci Rep."},{"issue":"6","key":"2024010518031104400_CIT0170","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/CCO.0000000000000876","article-title":"Management of epilepsy in brain tumor patients","volume":"34","author":"van der Meer","year":"2022","journal-title":"Curr Opin Oncol."}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/advance-article-pdf\/doi\/10.1093\/neuonc\/noad154\/51532278\/noad154.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/26\/1\/7\/55117426\/noad154.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/26\/1\/7\/55117426\/noad154.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T18:05:14Z","timestamp":1704477914000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/26\/1\/7\/7271494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,12]]},"references-count":170,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,9,12]]},"published-print":{"date-parts":[[2024,1,5]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noad154","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,1,1]]},"published":{"date-parts":[[2023,9,12]]}}}